D.A. Davidson & Co’s Fortress Biotech FBIO Stock Holding History

D.A. Davidson & Co’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-15	Closed	–	–	2111
2014 Q3	$0	Buy	+15	New	+$398	﹤0.01%	2126

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D.A. Davidson & Co's FBIO Position: Q4 2014 in Review

D.A. Davidson & Co sold out of Fortress Biotech (FBIO) in Q4 2014, closing a stake of 15 shares.

D.A. Davidson & Co first reported a position in FBIO in Q3 2014 and held it in 1 quarter. The position peaked at $0 in Q3 2014. 36 funds tracked by Wall St. Rank hold FBIO as of Q4 2014.

D.A. Davidson & Co reported no remaining Fortress Biotech position as of Q4 2014 after selling out during the quarter.
D.A. Davidson & Co sold 15 Fortress Biotech shares in Q4 2014.
D.A. Davidson & Co first reported a position in Fortress Biotech in Q3 2014 and held it in 1 quarter.
D.A. Davidson & Co's Fortress Biotech position peaked at $0 in Q3 2014.
36 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2014.

Based on D.A. Davidson & Co's 13F filing for Q4 2014, filed 12 Feb 2015.